CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Plasma cotinine levels and pancreatic cancer in the EPIC cohort study
Authors
M. Leenders Chuang, S.-C. Dahm, C.C. Overvad, K. Ueland, P.M. Midttun, O. Vollset, S.E. Tjønneland, A. Halkjær, J. Jenab, M. Clavel-Chapelon, F. Boutron-Ruault, M.-C. Kaaks, R. Canzian, F. Boeing, H. Weikert, C. Trichopoulou, A. Bamia, C. Naska, A. Palli, D. Pala, V. Mattiello, A. Tumino, R. Sacerdote, C. Van Duijnhoven, F.J.B. Peeters, P.H.M. Van Gils, C.H. Lund, E. Rodriguez, L. Duell, E.J. Pérez, M.-J.S. Molina-Montes, E. Castaño, J.M.H. Barricarte, A. Larrañaga, N. Johansen, D. Lindkvist, B. Sund, M. Ye, W. Khaw, K.-T. Wareham, N.J. Michaud, D.S. Riboli, E. Xun, W.W. Allen, N.E. Crowe, F.L. Bueno-De-Mesquita, H.B. Vineis, P.
Publication date
1 January 2012
Publisher
Abstract
Smoking is an established risk factor for pancreatic cancer, previously investigated by the means of questionnaires. Using cotinine as a biomarker for tobacco exposure allows more accurate quantitative analyses to be performed. This study on pancreatic cancer, nested within the European Prospective Investigation into Cancer and Nutrition (EPIC cohort), included 146 cases and 146 matched controls. Using liquid chromatography-mass spectrometry, plasma cotinine levels were analyzed on average 8.0 years before cancer onset (5-95% range: 2.8-12.0 years). The relation between plasma cotinine levels and pancreatic cancer was analyzed with conditional logistic regression for different levels of cotinine in a population of never and current smokers. This was also done for the self-reported number of smoked cigarettes per day at baseline. Every increase of 350 nmol/L of plasma cotinine was found to significantly elevate risk of pancreatic cancer [odds ratio (OR): 1.33, 95% confidence interval (CI): 1.11-1.60]. People with a cotinine level over 1187.8 nmol/L, a level comparable to smoking 17 cigarettes per day, have an elevated risk of pancreatic cancer, compared to people with cotinine levels below 55 nmol/L (OR: 3.66, 95% CI: 1.44-9.26). The results for self-reported smoking at baseline also show an increased risk of pancreatic cancer from cigarette smoking based on questionnaire information. People who smoke more than 30 cigarettes per day showed the highest risk compared to never smokers (OR: 4.15, 95% CI: 1.02-16.42). This study is the first to show that plasma cotinine levels are strongly related to pancreatic cancer. Copyright © 2011 UICC
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3090571
Last time updated on 10/02/2023